Form 4: Dexcom Executive Sells Shares
Insider Transaction (Form 4)
Jereme M Sylvain, EVP, Chief Financal Officer of Dexcom Inc, sold 3,638 shares of common stock on September 10, 2026 for $83.27 per share.
Summary
- Open-market sale: disposed of 3,638 Common Stock at $83.27 ($302,936) on September 10, 2026; holds 146,828 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $302,936 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jereme M Sylvain — Officer (EVP, Chief Financal Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-10 | Open-market sale | Common Stock | 3,638 | $83 | $302.9K | 146,828 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-10 | Open-market sale (3,638 shares) |
Keywords
insider transaction, Form 4, DXCM, DEXCOM INC, bearish, Jereme M Sylvain
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.